What Does Strand Therapeutics Do?

Total employees92
HeadquartersCambridge
Founded2017

Strand Therapeutics is a clinical-stage biopharmaceutical company at the forefront of developing next-generation mRNA therapeutics. They are pioneering programmable, self-replicating mRNA technology designed to create long-acting immunotherapies. Their initial focus is on oncology, aiming to deliver precisely targeted treatments that can overcome the limitations of current therapies. By engineering mRNA to sense and respond to disease biomarkers, Strand aims to improve efficacy and reduce side effects, ultimately transforming the treatment landscape for cancer and potentially other diseases. Their lead candidate, STX-001, is the first programmable, self-replicating mRNA therapy being evaluated for solid tumors.

Where Is Strand Therapeutics's Headquarters?

Strand Therapeutics officeStrand Therapeutics officeStrand Therapeutics officeStrand Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Cambridge headquarters serves as the primary center for Strand Therapeutics' research and development, laboratory operations, corporate administration, and strategic leadership in advancing its novel mRNA platform.

Notable Features:

The facility is equipped with state-of-the-art BSL-2 laboratory spaces essential for advanced mRNA research, synthesis, and preclinical development. It also features collaborative office environments designed to foster scientific innovation and teamwork.

Work Culture:

Strand Therapeutics cultivates a dynamic, innovative, and science-driven work culture. There is a strong emphasis on collaboration, cutting-edge research, and a collective mission to translate scientific breakthroughs into impactful patient therapies in a fast-paced biotech environment.

HQ Significance:

Its Cambridge location is highly significant, placing Strand Therapeutics within one of the world's leading biotechnology ecosystems. This provides unparalleled access to top-tier talent, renowned research institutions, potential collaborators, and venture capital.

Values Reflected in HQ: The headquarters reflects Strand's core values of scientific excellence, relentless innovation, patient-centricity, and collaboration, underscored by its strategic presence in a leading biotech hub.

Location:

Strand Therapeutics' primary operations are currently concentrated in the United States at its Cambridge, MA headquarters. As a clinical-stage company, its global activities may include international clinical trial sites and research collaborations. Future global presence will likely expand with the clinical and commercial development of its mRNA therapeutic pipeline, potentially through strategic partnerships for market access in different regions.

Street Address:

60 Tufts Street

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Strand Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Strand Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Strand Therapeutics? Meet the Executive Team

As of April 2025, Strand Therapeutics' leadership includes:

Jacob Becraft, Ph.D. - Co-founder & Chief Executive Officer
Tasuku Kitada, Ph.D. - Co-founder, President & Head of R&D
Justin Huck - Chief Financial Officer
Prashant Nambiar, DVM, Ph.D., DACVP, FIATP - Chief Scientific Officer
Osvaldo Flores, Ph.D. - Chief Technology Officer
Yasir Al-Wakeel, BM BCh - Chief Medical Officer
Christopher K. Lee, MBA - Chief Operating Officer
Robert Mabry, Ph.D. - Chief Development Officer

Who's Investing in Strand Therapeutics?

Strand Therapeutics has been backed by several prominent investors over the years, including:

Playground Global
ANRI
ARTIS Ventures
FKD Capital
Camford Capital
Alexandria Venture Investments
Redmile Group
BeiGene
Merck Global Health Innovation Fund (MGHIF)
Lilly Asia Ventures (LAV)
Intensity Capital
National Cancer Institute (NCI)

What Leadership Changes Has Strand Therapeutics Seen Recently?

Hire2
Exits0

Over the past 12 months, Strand Therapeutics has made significant additions to its executive leadership team, appointing a new Chief Operating Officer and a Chief Development Officer. These hires signal the company's focus on scaling operations and advancing its clinical pipeline. No major executive departures have been publicly announced during this period.

New Appointments:

Christopher K. Lee, MBA, Christopher K. Lee was appointed as Chief Operating Officer to lead Strand's operational functions, including manufacturing and supply chain, as the company scales its platform.
Robert Mabry, Ph.D., Robert Mabry, Ph.D., joined as Chief Development Officer to spearhead preclinical and clinical development strategies for Strand's programmable mRNA therapeutics.

What Technology (Tech Stack) Is Used byStrand Therapeutics?

Discover the tools Strand Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Strand Therapeutics Email Formats and Examples

Strand Therapeutics likely utilizes common corporate email address formats. Based on industry standards and company naming conventions, the most probable format is [first_initial][last]@[domain] or [first].[last]@[domain]. The company's domain is strandtx.com.

[first_initial][last]@strandtx.com

Format

jbecraft@strandtx.com

Example

85%

Success rate

What's the Latest News About Strand Therapeutics?

GlobeNewswire • March 21, 2024

Strand Therapeutics Appoints Robert Mabry, Ph.D., as Chief Development Officer

Strand Therapeutics announced the appointment of Robert Mabry, Ph.D., as its Chief Development Officer. Dr. Mabry will oversee the company's preclinical and clinical development strategies for its pipeline of programmable mRNA therapeutics....more

GlobeNewswire • January 9, 2024

Strand Therapeutics Appoints Christopher K. Lee, MBA, as Chief Operating Officer

Strand Therapeutics appointed Christopher K. Lee, MBA, as its Chief Operating Officer. Mr. Lee will be responsible for leading the company's operational functions, including manufacturing, supply chain, quality, and program management....more

GlobeNewswire • September 7, 2023

Strand Therapeutics Announces FDA Clearance of IND Application for STX-001, First Programmable, Self-Replicating mRNA Therapy for Solid Tumors

Strand Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for STX-001. This marks the first IND clearance for a programmable, self-replicating mRNA therapy designed for the treatment of solid tumors....more

GlobeNewswire • May 10, 2023

Strand Therapeutics Appoints Yasir Al-Wakeel, BM BCh as Chief Medical Officer

Strand Therapeutics appointed Yasir Al-Wakeel, BM BCh, as its Chief Medical Officer. Dr. Al-Wakeel will lead the clinical development strategy and operations for Strand's pipeline of next-generation mRNA therapeutics....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Strand Therapeutics, are just a search away.